Scott A Maxson

Title: Scott A Maxson: Innovator in Cartilage Products

Introduction

Scott A Maxson is a notable inventor based in Columbia, MD (US), recognized for his contributions to the field of cartilage products. With a total of five patents to his name, Maxson has made significant advancements in the development of innovative cartilage solutions.

Latest Patents

Maxson's latest patents include a non-cultured, partially digested, cryopreserved cartilage product. This invention provides porated cartilage products and methods for producing them. The cartilage products can be sized, porated, and digested to create a flexible cartilage product. Additionally, these products may contain viable chondrocytes, bioactive factors such as chondrogenic factors, and a collagen type II matrix, and they are designed to be non-immunogenic. Another significant patent is for disrupted cartilage products, which details methods of manufacturing these products and treating subjects by administering the cartilage product. This process involves disrupting a collagen matrix to produce a flexible cartilage product, which may also include viable chondrocytes and bioactive factors.

Career Highlights

Throughout his career, Scott A Maxson has worked with various companies, including Osiris Therapeutics, Inc. His work has focused on advancing the science of cartilage products, contributing to both research and practical applications in the field.

Collaborations

Maxson has collaborated with notable colleagues, including Dana Sue Yoo and Jin-Qiang Kuang, enhancing the innovation process through teamwork and shared expertise.

Conclusion

Scott A Maxson's innovative work in cartilage products showcases his commitment to advancing medical technology. His patents reflect a deep understanding of cartilage science and its applications, making him a significant figure in the field.